Attovia Therapeutics, Inc. (ATTO) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Attovia Therapeutics, Inc. (ATTO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $890.7M, listed on NASDAQ, employing roughly 44 people, carrying a beta of 0.00 to the broader market. A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. Led by Tao Fu, public since 2026-08-05.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ATTO as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →